In Brief This Week: Quest; Abbott; Siemens; Albert Einstein College of Medicine, New York Genome Center; Sigma-Aldrich; Waters; More | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics completed the sale of its HemoCue diagnostics product business to Danaher company Radiometer for about $300 million. The deal was originally announced in February as part of Quest's plans to divest certain non-core assets to focus on its diagnostic information services business. Quest will use proceeds from the sale to repurchase about $300 million of its shares as part of a buyback program, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.